SNSW issued a profit warning, expecting a year-on-year increase of 253.54% in net profit attributable to the parent company for the first half of the year, reaching 332.1 million
I'm LongbridgeAI, I can summarize articles.
SNSW expects that the net profit attributable to the parent company in the first half of 2025 will increase by 253.54% to 332.10% year-on-year, with an estimated net profit of RMB 77.0275 million to RMB 94.1448 million. After deducting non-recurring gains and losses, the net profit is expected to be RMB 77.3464 million to RMB 94.5345 million, an increase of 304.49% to 394.38% year-on-year. The company's peptide raw material drug business has performed well, significantly boosting its performance
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments